Alloplex’s Abstract (3599) ‘Interleukin-10 and transforming growth factor-beta do not suppress tumor killing activity of PBMC-derived SUPLEXA cells’ has been accepted by AACR and is scheduled for presentation in a Poster session at the 2022 Annual Meeting.
We look forward to attending this year’s meeting in New Orleans, Louisiana, from April 8 to 13, in person and to seeing as many of you there.
Please click the following link for more information: https://www.aacr.org/meeting/aacr-annual-meeting-2022/
To request interviews, high res images or other materials, media are asked to:
Email: media@alloplexbio.com
Attn: Lesley White, Alloplex Australia
For media requests on deadline during USA Eastern hours, please call: +1-781-281-2013
